Birzeit Pharmaceuticals Company (PEX:BPC)
3.600
-0.050 (-1.37%)
At close: Sep 3, 2025
PEX:BPC Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 12.99 | 5.18 | 6.12 | 7.95 | 12.08 | 7.37 | Upgrade |
Depreciation & Amortization | 1.43 | 1.42 | 1.5 | 1.66 | 1.66 | 1.69 | Upgrade |
Loss (Gain) From Sale of Assets | -0 | 0 | -0.05 | -0.05 | -0.16 | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | 0.69 | -0.27 | - | Upgrade |
Loss (Gain) From Sale of Investments | -0.42 | 1.63 | 1.24 | -0.88 | -2.03 | -0.99 | Upgrade |
Provision & Write-off of Bad Debts | 0.21 | - | 0.85 | 0.21 | 0.17 | 0.27 | Upgrade |
Other Operating Activities | -0.03 | 0 | 1.73 | 1.08 | 2.21 | 1.57 | Upgrade |
Change in Accounts Receivable | -9.49 | -5.78 | -0.04 | -5.21 | -10.55 | 1.41 | Upgrade |
Change in Inventory | 1.64 | 1.3 | -0.93 | -0.55 | 0.54 | 0.23 | Upgrade |
Change in Accounts Payable | -2.59 | - | - | - | - | - | Upgrade |
Change in Other Net Operating Assets | 3.49 | 3.2 | 1.77 | 0.3 | -0.01 | -5.91 | Upgrade |
Operating Cash Flow | 7.23 | 6.96 | 12.16 | 5.21 | 3.65 | 5.63 | Upgrade |
Operating Cash Flow Growth | -4.75% | -42.79% | 133.66% | 42.70% | -35.22% | -49.09% | Upgrade |
Capital Expenditures | -2.93 | -1.52 | -3.33 | -3.59 | -0.93 | -0.5 | Upgrade |
Sale of Property, Plant & Equipment | 0.02 | - | - | 0.05 | - | - | Upgrade |
Cash Acquisitions | 0.01 | -0.02 | -0.13 | - | -0.01 | -0.24 | Upgrade |
Divestitures | 0.04 | - | - | 0.01 | - | - | Upgrade |
Sale (Purchase) of Real Estate | - | - | 0.32 | - | 0.96 | -1.63 | Upgrade |
Investment in Securities | -1.75 | -3.49 | -3.86 | 3.48 | -1.13 | -0.58 | Upgrade |
Investing Cash Flow | -4.6 | -5.04 | -7.01 | -0.05 | -1.11 | -2.95 | Upgrade |
Long-Term Debt Repaid | - | - | -1.22 | -0.82 | -1.17 | -1.17 | Upgrade |
Net Debt Issued (Repaid) | - | - | -1.22 | -0.82 | -1.17 | -1.17 | Upgrade |
Issuance of Common Stock | 0 | 0 | 0 | - | - | - | Upgrade |
Repurchase of Common Stock | - | - | - | -0.08 | -0.01 | -0 | Upgrade |
Common Dividends Paid | -1.94 | -1.94 | -3.88 | -1.94 | -2.85 | -4.18 | Upgrade |
Financing Cash Flow | -1.93 | -1.94 | -5.09 | -2.84 | -4.03 | -5.35 | Upgrade |
Foreign Exchange Rate Adjustments | 0.17 | -0.02 | 0.05 | -0.45 | 0.07 | 0.2 | Upgrade |
Net Cash Flow | 0.86 | -0.04 | 0.11 | 1.86 | -1.42 | -2.47 | Upgrade |
Free Cash Flow | 4.3 | 5.43 | 8.83 | 1.62 | 2.72 | 5.13 | Upgrade |
Free Cash Flow Growth | -8.46% | -38.45% | 446.04% | -40.51% | -47.00% | -25.04% | Upgrade |
Free Cash Flow Margin | 9.41% | 13.37% | 20.47% | 3.44% | 5.98% | 14.30% | Upgrade |
Free Cash Flow Per Share | 0.11 | 0.14 | 0.23 | 0.04 | 0.07 | 0.13 | Upgrade |
Cash Income Tax Paid | 0.02 | 0.03 | 0.03 | 0.03 | - | 0 | Upgrade |
Levered Free Cash Flow | -0.3 | 4.76 | 5.21 | -0.98 | -1.17 | 5.59 | Upgrade |
Unlevered Free Cash Flow | -0.27 | 4.78 | 5.27 | -0.91 | -1.04 | 5.73 | Upgrade |
Change in Working Capital | -6.95 | -1.28 | 0.79 | -5.46 | -10.02 | -4.27 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.